Previous close | 71.39 |
Open | 71.86 |
Bid | 70.08 x N/A |
Ask | 70.88 x N/A |
Day's range | 70.08 - 71.90 |
52-week range | 15.12 - 72.16 |
Volume | |
Avg. volume | 590,253 |
Market cap | 8.375B |
Beta (5Y monthly) | 2.35 |
PE ratio (TTM) | 19.29 |
EPS (TTM) | 3.64 |
Earnings date | 24 Jul 2024 - 29 Jul 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 71.45 |
Based on the average brokerage recommendation (ABR), Celestica (CLS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
CLS, DXPE, FBP, RCMT and SIGA have been added to the Zacks Rank #1 (Strong Buy) List on May 17, 2024.
Celestica (CLS) is well positioned to outperform the market, as it exhibits above-average growth in financials.